001680 DAESANG CORPORATION — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

₩17,220

Period return

-3,380 (-16.41%)

Volume

32.9K

2026-07-20O ₩17,390 H ₩17,390 L ₩16,940 C ₩17,220MA5 ₩17,366MA20 ₩17,463MA60 ₩19,202MA120 ₩20,342

6M · 124 barsKRX · KRW2026-01-02 → 2026-07-20

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 07. 01.Medium21 days ago
5% 대량보유 — 국민연금공단
국민연금공단의 지분 변동 -1.01%p (현재 10.67%)
2026. 06. 05.Medium2 months ago
하나증권 — 1Q26 Re: 2분기까지 전년 베이스 부담
2026. 06. 01.Medium2 months ago
교보증권 — 트리거가 필요해
2026. 05. 15.Medium2 months ago
2026년 1분기 실적 발표
매출 1.1조. 세부 수치와 가이던스는 원문에서 확인하세요.
2026. 02. 06.Medium6 months ago
5% 대량보유 — 베어링자산운용
베어링자산운용의 지분 변동 -1.00%p (현재 4.01%)
2026. 01. 02.Medium7 months ago
5% 대량보유 — 국민연금공단
국민연금공단의 지분 변동 -1.04%p (현재 11.68%)
2025. 11. 14.Medium8 months ago
2025년 3분기 실적 발표
매출 1.1조. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 08. 14.Medium11 months ago
2025년 2분기 실적 발표
EPS 493 · 매출 1.1조. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 07. 02.Mediumlast year
5% 대량보유 — KB자산운용
KB자산운용의 지분 변동 +1.00%p (현재 6.02%)
2025. 05. 15.Mediumlast year
2025년 1분기 실적 발표
매출 1.1조. 세부 수치와 가이던스는 원문에서 확인하세요.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Rating & price-target changes

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

Daesang posted Q1 consolidated revenue of KRW 1.11 trillion (down 2% YoY) and operating profit of KRW 57.0 billion (flat YoY). While the Food division fared well, the Materials division struggled due to the base effect from anti-dumping duties and decreased demand. Indonesia saw improved profitability, but Vietnam's profitability deteriorated due to intensifying competition. Overall industry conditions remain challenging, with a turnaround for the Bio division anticipated in Q2. This summary is automatically generated research assistance information based on publicly available data and does not constitute a recommendation to buy or sell. Investment decisions are solely the user's responsibility.

Q1 Consolidated Revenue and Operating Profit Stagnation
Food Segment Revenue and Operating Profit Growth
Continued Underperformance in Materials Segment
Indonesia Subsidiary Profitability Improvement
Q2 Lysine Profitability Improvement Outlook

Confidence score 72%

Major shareholders (DART)

5%+ stakes and insider ownership filings

Filings tab →

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
FY2026 Q1	2026. 05. 15.	Time TBD	—	—	—	—	₩1.11T	Reported
FY2025 Q3	2025. 11. 14.	Time TBD	—	—	—	—	₩1.15T	Reported
FY2025 Q2	2025. 08. 14.	Time TBD	—	₩493	—	—	₩1.08T	Reported
FY2025 Q1	2025. 05. 15.	Time TBD	—	—	—	—	₩1.13T	Reported

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 06. 05.	하나증권	—	Maintain	— → —	—	1Q26 Re: 2분기까지 전년 베이스 부담
2026. 06. 01.	교보증권	권우정	Maintain	— → BUY	34,000 → 34,000	트리거가 필요해

DAESANG CORPORATION대상

Price chart

Recent event timeline

Recent earnings

Research actions

Company info

Top news

Key stats